Financial Health Report: Elevation Oncology Inc (ELEV)’s Ratios Tell a Tale

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Elevation Oncology Inc (NASDAQ: ELEV) closed the day trading at $0.65 up 11.71% from the previous closing price of $0.59. In other words, the price has increased by $11.71 from its previous closing price. On the day, 1.14 million shares were traded. ELEV stock price reached its highest trading level at $0.6788 during the session, while it also had its lowest trading level at $0.59.

Ratios:

For a better understanding of ELEV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 41.10 and its Current Ratio is at 41.10. In the meantime, Its Debt-to-Equity ratio is 0.38 whereas as Long-Term Debt/Eq ratio is at 0.38.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.

On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $8.

On March 01, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $7.JMP Securities initiated its Mkt Outperform rating on March 01, 2024, with a $7 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 38638116 and an Enterprise Value of -45343696.

Stock Price History:

Over the past 52 weeks, ELEV has reached a high of $5.83, while it has fallen to a 52-week low of $0.36. The 50-Day Moving Average of the stock is 3.03%, while the 200-Day Moving Average is calculated to be -75.60%.

Shares Statistics:

Over the past 3-months, ELEV traded about 1.14M shares per day on average, while over the past 10 days, ELEV traded about 633860 shares per day. A total of 59.11M shares are outstanding, with a floating share count of 49.99M. Insiders hold about 15.43% of the company’s shares, while institutions hold 84.44% stake in the company. Shares short for ELEV as of 1727654400 were 6148989 with a Short Ratio of 5.41, compared to 1724976000 on 6570392. Therefore, it implies a Short% of Shares Outstanding of 6148989 and a Short% of Float of 10.99.

Most Popular